130 related articles for article (PubMed ID: 38309583)
21. Surface dose rate variations in planar and curved geometries of
Bakshi AK; Shrivastava V; Chattaraj A; Samuel K; Palani Selvam T; Sapra BK; Sinharoy P; Banerjee D; Sugilala G; Manohar S; Kaushik CP
Phys Med; 2021 Sep; 89():200-209. PubMed ID: 34399207
[TBL] [Abstract][Full Text] [Related]
22. ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations.
Strnad V; Major T; Polgar C; Lotter M; Guinot JL; Gutierrez-Miguelez C; Galalae R; Van Limbergen E; Guix B; Niehoff P; Lössl K; Hannoun-Levi JM
Radiother Oncol; 2018 Sep; 128(3):411-420. PubMed ID: 29691075
[TBL] [Abstract][Full Text] [Related]
23. A survey of physics and dosimetry practice of permanent prostate brachytherapy in the United States.
Prete JJ; Prestidge BR; Bice WS; Friedland JL; Stock RG; Grimm PD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):1001-5. PubMed ID: 9531387
[TBL] [Abstract][Full Text] [Related]
24. First clinical implementation of Yttrium-90 Disc Brachytherapy after FDA clearance.
Finger PT; Stewart R; Rivard MJ; Beers RJ; Kamen J; Lama S; Chin KJ; Mohney K; Welles TS; Sauerwein WAG; Rosenzweig K
Brachytherapy; 2023; 22(3):416-427. PubMed ID: 36948988
[TBL] [Abstract][Full Text] [Related]
25. Dual-source strength seed loading for eye plaque brachytherapy using eye physics eye plaques: A feasibility study.
Meltsner SG; Kirsch DG; Materin MA; Kim Y; Sheng Y; Craciunescu O
J Contemp Brachytherapy; 2022 Dec; 14(6):590-600. PubMed ID: 36819471
[TBL] [Abstract][Full Text] [Related]
26. Dose characteristics of Au-198 eye brachytherapy applicator: A Monte Carlo study.
Kamrani S; Aghamiri SMR; Hashemi S
Appl Radiat Isot; 2021 Oct; 176():109866. PubMed ID: 34293507
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
[TBL] [Abstract][Full Text] [Related]
28. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate
Ma Y; Vijande J; Ballester F; Tedgren ÅC; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith R; Chamberland MJP; Thomson RM; Verhaegen F; Beaulieu L
Med Phys; 2017 Nov; 44(11):5961-5976. PubMed ID: 28722180
[TBL] [Abstract][Full Text] [Related]
29. Feasibility study of defining planning target volume using surgical margins in permanent breast seed implant brachytherapy.
Zhang C; Hilts M; Batchelar D; Crook J
Brachytherapy; 2023; 22(1):101-107. PubMed ID: 36244908
[TBL] [Abstract][Full Text] [Related]
30. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
31. The impact of prescription depth, dose rate, plaque size, and source loading on the central axis using 103Pd, 125I, and 131Cs.
Rivard MJ; Melhus CS; Sioshansi S; Morr J
Brachytherapy; 2008; 7(4):327-35. PubMed ID: 18782684
[TBL] [Abstract][Full Text] [Related]
32. (106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence.
Barker CA; Francis JH; Cohen GN; Marr BP; Wolden SL; McCormick B; Abramson DH
Brachytherapy; 2014; 13(6):584-90. PubMed ID: 24880583
[TBL] [Abstract][Full Text] [Related]
33. GEC-ESTRO ACROP recommendations in skin brachytherapy.
Guinot JL; Rembielak A; Perez-Calatayud J; Rodríguez-Villalba S; Skowronek J; Tagliaferri L; Guix B; Gonzalez-Perez V; Valentini V; Kovacs G;
Radiother Oncol; 2018 Mar; 126(3):377-385. PubMed ID: 29455924
[TBL] [Abstract][Full Text] [Related]
34. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
35. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy.
Pötter R; Van Limbergen E; Gerstner N; Wambersie A
Radiother Oncol; 2001 Jan; 58(1):11-8. PubMed ID: 11165676
[TBL] [Abstract][Full Text] [Related]
36. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer.
Haack S; Pedersen EM; Jespersen SN; Kallehauge JF; Lindegaard JC; Tanderup K
Acta Oncol; 2010 Oct; 49(7):978-83. PubMed ID: 20831485
[TBL] [Abstract][Full Text] [Related]
37. Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.
Gagne NL; Leonard KL; Rivard MJ
Med Phys; 2012 Jun; 39(6):3332-42. PubMed ID: 22755715
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma.
Dean MK; Studenski MT; Paez-Escamilla MA; Walter SD; Kwon D; Markoe AM; Harbour JW; Samuels SE
Brachytherapy; 2019; 18(3):404-410. PubMed ID: 30797699
[TBL] [Abstract][Full Text] [Related]
39. Personalized treatment planning in eye brachytherapy for ocular melanoma: Dosimetric analysis on ophthalmic structure at risk.
Itta F; Liuzzi R; Farella A; Porri G; Pacelli R; Conson M; Oliviero C; Buonanno F; Breve MA; Cennamo G; Clemente S; Cella L
Phys Med; 2020 Aug; 76():285-293. PubMed ID: 32738776
[TBL] [Abstract][Full Text] [Related]
40. Patterns of practice survey for cervical cancer brachytherapy in Morocco.
Chekrine T; Bellefkih FZ; Hatim G; Bouchbika Z; Benchakroun N; Jouhadi H; Tawfiq N; Sahraoui S
Brachytherapy; 2024; 23(2):154-164. PubMed ID: 38311545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]